Abraxane for Breast Cancer User Reviews
Abraxane has an average rating of 9.7 out of 10 from a total of 3 reviews for the treatment of Breast Cancer. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
- Miche...
- Taken for 1 to 6 months
- November 24, 2014
"Have just finished 12 weeks of this for Stage 2 breast cancer. After my first chemo I was told to go and buy some gastro stop for the drive home but I have been very lucky. The only side effects I have had is some aching in my thumbs but I can live with that. I am now about to start Femara for five years and reading some of the reviews and side effects a bit worried."
- Scree...
- Taken for 6 months to 1 year
- October 28, 2012
"This medicine saved my life! I received it weekly for 6 months."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Breast Cancer
- Breast Cancer Guide
- Breast Cancer: Treatment and Prevention Options
- Cancer Center
- FDA-Approved Weight Loss Drugs: Can They Help You?
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about Abraxane (paclitaxel protein-bound)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: mitotic inhibitors
- En español
"Helped lower tumor markers significantly when recurrence occurred. Slowed cancer growth for 6 mos before neuropathy got too bad. Did not make my wife as sick as Adriamycin/Cytoxin which was her primary treatment at first occurrence. On the downside, our insurance company, BCBS Illinois did not cover Abraxane and we were left with a $54,000 bill. Drug company eventually provided replacement drug as hardship."